<unk>  is a hemostatic that is FDA approved for the treatment of congenital Factor<unk>  deficiency.   Common adverse reactions include joint inflammation, hypersensitivity, rash, pruritus, erythema, hematoma, arthralgia, headache, elevated thrombin-antithrombin levels, and increased blood lactate dehydrogenase.
Factor XIII concentrate
Prothrombin complex concentrate
Recombinant factor VIIa
Rapid plasma reagent
Vitamin K antagonist
Factor Xa inhibitor antidote
Vitamin K
Fragmin injection